Ireland
--:--IST
Recruiting Observational

Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers

NCT06626243 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2024-09-30
Last updated
2024-11-29

Condition(s) studied

Non-Small Cell Lung Cancer

Study summary

The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving neoadjuvant chemo-immunotherapy.

There are no risks for the patients, as this is a retrospective data collection.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of clinical or pathological stage IIB (T1-2, hilar N1, M0) and III (any T, N1-2, M0) NSCLC surgically treated with robotic, VATS and open approach with radical intent from 1st of January 2016 to 31st of March 2024 * Received neoadjuvant chemo-immunotherapy or immunotherapy alone * Age \>= 18 years old at the moment of surgery Exclusion Criteria: * Age \<18 years old at the moment of surgery

Primary outcome measure(s)

  • The perioperative complication of video-assisted thoracoscopic surgery (VATS) approach — 30-90 days after surgery
    The investigators will measure the perioperative complications of VATS approach in patients who received neoadjuvant chemo-immunotherapy. Complications will be categorized according to the Clavien-Dindo scale.
  • The perioperative complications of robotic approach — from the surgery at 30-90 days after
    The investigators will measure the perioperative complications of robotic lung resection in patients who received neoadjuvant chemo-immunotherapy. Complications will be categorized according to the Clavien-Dindo scale.
  • The perioperative complications of the open approach — 30-90 days after surgery
    The investigators will measure the perioperative complications of open approach in patients who received neoadjuvant chemo-immunotherapy. Complications will be categorized according to the Clavien-Dindo scale.

Trial sites (6)

FacilityCityRegionStatus
Baptist Health South Florida Miami Florida Recruiting
Memorial Sloan Kettering Cancer Center New York New York Recruiting
West Virginia University Morgantown West Virginia Recruiting
Istituto Clinico Humanitas Rozzano Milan Recruiting
Scientific Institute Ospedale San Raffaele Milan Italy Recruiting
Regina Elena National Cancer Institute Rome Italy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06626243 on ClinicalTrials.gov ↗ ← All trials in Italy